Senior insider sale
CHIEF EXECUTIVE OFFICER at WHITEHAWK THERAPEUTICS, INC. — senior position signals high conviction
$1.02M
296.75K shares
What this filing means
LENNON DAVID JAMES plans to sell 296.75K shares of WHITEHAWK THERAPEUTICS, INC. valued at approximately $1.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/9/2026ACC: 0001995275-26-000011
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
296.75K
Shares to sell
$1.02M
Approx. market value
775.83K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/1/2026
775.83KTotal acquired775.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Restricted Stock Units N/A | 775.83K | — |
| Total | 775.83K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
63.95K
Market value
$217.4K
4/8/2026
—Completed
Units to sell
94.09K
Market value
$322.7K
4/7/2026
—Completed
Units to sell
102.39K
Market value
$359.4K
4/6/2026
—Completed
Units to sell
26.86K
Market value
$93.5K
4/2/2026
—Completed
Units to sell
5.10K
Market value
$16.9K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.36K
Market value
$14.8K
4/9/2026
Total
Units
296.75K
Value
$1.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/8/2026 | 63.95K | $217.4K | — | Completed |
4/7/2026 | 94.09K | $322.7K | — | Completed |
4/6/2026 | 102.39K | $359.4K | — | Completed |
4/2/2026 | 26.86K | $93.5K | — | Completed |
3/2/2026 | 5.10K | $16.9K | — | Completed |
| Planned — Approximate Date | ||||
4/9/2026 | 4.36K | $14.8K | NASDAQ | Planned |
| Total | 296.75K | $1.02M | ||